Cargando…

The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes

PURPOSE: To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. METHOD: Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were divided into 2 cohorts on the basis of their sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shang-Yi, Chen, Hsin-Hung, Lin, Cheng-Li, Yeh, Su-Yin, Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747869/
https://www.ncbi.nlm.nih.gov/pubmed/31555067
http://dx.doi.org/10.1177/1559325819876766
_version_ 1783451994518716416
author Li, Shang-Yi
Chen, Hsin-Hung
Lin, Cheng-Li
Yeh, Su-Yin
Kao, Chia-Hung
author_facet Li, Shang-Yi
Chen, Hsin-Hung
Lin, Cheng-Li
Yeh, Su-Yin
Kao, Chia-Hung
author_sort Li, Shang-Yi
collection PubMed
description PURPOSE: To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. METHOD: Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were divided into 2 cohorts on the basis of their statin use, namely hydrophilic statin and lipophilic statin. We used Cox proportional hazard regression models to analyze the risks of cardiovascular outcomes. RESULT: In this study, 12 896 patients used statin, including 4259 patients using hydrophilic statin and 8637 patients using lipophilic statin. With 12-year follow-up, higher incidence rate of coronary artery disease and stroke was noted in the lipophilic statin use instead of hydrophilic statin use. CONCLUSION: According to our long-term cohort study, hydrophilic statin use may be a better choice than lipophilic statin to reduce cardiovascular events in Asian diabetic patients.
format Online
Article
Text
id pubmed-6747869
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-67478692019-09-25 The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes Li, Shang-Yi Chen, Hsin-Hung Lin, Cheng-Li Yeh, Su-Yin Kao, Chia-Hung Dose Response Original Article PURPOSE: To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. METHOD: Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were divided into 2 cohorts on the basis of their statin use, namely hydrophilic statin and lipophilic statin. We used Cox proportional hazard regression models to analyze the risks of cardiovascular outcomes. RESULT: In this study, 12 896 patients used statin, including 4259 patients using hydrophilic statin and 8637 patients using lipophilic statin. With 12-year follow-up, higher incidence rate of coronary artery disease and stroke was noted in the lipophilic statin use instead of hydrophilic statin use. CONCLUSION: According to our long-term cohort study, hydrophilic statin use may be a better choice than lipophilic statin to reduce cardiovascular events in Asian diabetic patients. SAGE Publications 2019-09-16 /pmc/articles/PMC6747869/ /pubmed/31555067 http://dx.doi.org/10.1177/1559325819876766 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Li, Shang-Yi
Chen, Hsin-Hung
Lin, Cheng-Li
Yeh, Su-Yin
Kao, Chia-Hung
The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes
title The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes
title_full The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes
title_fullStr The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes
title_full_unstemmed The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes
title_short The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes
title_sort different cardiovascular outcomes between long-term efficacy of hydrophilic and lipophilic statin therapy in both asian diabetic sexes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747869/
https://www.ncbi.nlm.nih.gov/pubmed/31555067
http://dx.doi.org/10.1177/1559325819876766
work_keys_str_mv AT lishangyi thedifferentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes
AT chenhsinhung thedifferentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes
AT linchengli thedifferentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes
AT yehsuyin thedifferentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes
AT kaochiahung thedifferentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes
AT lishangyi differentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes
AT chenhsinhung differentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes
AT linchengli differentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes
AT yehsuyin differentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes
AT kaochiahung differentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes